BDBM50313179 (R)-2-((S)-1-ethyl-3-methyl-4-(4-(trifluoromethyl)phenethyl)-6,7-dihydro-1H-pyrazolo[4,3-c]pyridin-5(4H)-yl)-N-methyl-2-phenylacetamide::CHEMBL1081252
SMILES: CCn1nc(C)c2[C@H](CCc3ccc(cc3)C(F)(F)F)N(CCc12)[C@@H](C(=O)NC)c1ccccc1
InChI Key: InChIKey=VDTFQQQTVJPZLY-WIOPSUGQSA-N
Data: 2 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Orexin receptor type 2 (Homo sapiens (Human)) | BDBM50313179 ((R)-2-((S)-1-ethyl-3-methyl-4-(4-(trifluoromethyl)...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Actelion Pharmaceuticals Ltd Curated by ChEMBL | Assay Description Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay | Bioorg Med Chem Lett 20: 1539-42 (2010) Article DOI: 10.1016/j.bmcl.2010.01.070 BindingDB Entry DOI: 10.7270/Q2FB5324 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin receptor type 1 (Homo sapiens (Human)) | BDBM50313179 ((R)-2-((S)-1-ethyl-3-methyl-4-(4-(trifluoromethyl)...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 128 | n/a | n/a | n/a | n/a | n/a | n/a |
Actelion Pharmaceuticals Ltd Curated by ChEMBL | Assay Description Antagonist activity at human OX1 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay | Bioorg Med Chem Lett 20: 1539-42 (2010) Article DOI: 10.1016/j.bmcl.2010.01.070 BindingDB Entry DOI: 10.7270/Q2FB5324 | |||||||||||
More data for this Ligand-Target Pair |